| EMA number | EMEA/H/C/000745 |
| ATC code | V08CA06 |
| Authorisation | 23 July 2007 |
| Withdrawn | 25 July 2017 |
| Revision | 14 |
This medicinal product is for diagnostic use only. Optimark is indicated for use with magnetic resonance imaging (MRI) of the central nervous system (CNS) and liver. It provides contrast enhancement and facilitates visualisation and helps with the characterisation of focal lesions and abnormal structures in the CNS and liver in patients with known or highly suspected pathology.